Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-83,689
Closed -$2.32M 126
2014
Q3
$2.32M Buy
83,689
+652
+0.8% +$18.3K 2.28% 10
2014
Q2
$2.4M Buy
+83,037
New +$2.37M 2.37% 10

Other funds holding PFE

L.J. Altfest & Co's PFE Position: Q1 2026 in Review

L.J. Altfest & Co reduced its Pfizer (PFE) stake by 0.27% in Q1 2026, selling an estimated $2.42K and leaving 33,028 shares worth $927K. The position accounts for 0.1% of the portfolio, ranked #149.

L.J. Altfest & Co first reported a position in PFE in Q4 2013 and has held it in 47 quarters since. The position peaked at $3.77M in Q3 2017. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • L.J. Altfest & Co held 33,028 shares of Pfizer worth $927K as of Q1 2026.
  • L.J. Altfest & Co sold 91 Pfizer shares in Q1 2026, an estimated $2.42K.
  • Pfizer made up 0.1% of L.J. Altfest & Co's portfolio in Q1 2026, its #149 holding.
  • L.J. Altfest & Co first reported a position in Pfizer in Q4 2013 and has held it in 47 quarters since.
  • L.J. Altfest & Co's Pfizer position peaked at $3.77M in Q3 2017.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on L.J. Altfest & Co's 13F filing for Q1 2026, filed 28 Apr 2026.